Bristol Myers dips on ‘confounding’ lung drug results
Yahoo! Finance USA,
Dive Brief: Bristol Myers Squibb said Monday that its experimental lung disease drug admilparant succeeded in a Phase 3 trial…
Bristol Myers trial revisions shake confidence in new class of fibrosis drugs
Yahoo! Finance USA,
Dive Brief: Bristol Myers Squibb has changed a late-stage study of its experimental pulmonary fibrosis drug admilparant to more…
Contineum: LPA1R Antagonist Drug Advancement Against IPF With Proven Track Model
Seeking Alpha,
Follow Summary Contineum Therapeutics, Inc. PIPE-791 is being developed for the treatment of neuroinflammatory disorders like…
